Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Casertano

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Neurology|September 3, 2020
Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodiesS Casertano, E Signoriello, F Rossi, et al.
Multiple Sclerosis and Related Disorders|May 26, 2020
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumabE Signoriello, S Bonavita, A Di Pietro, et al.
Nature|June 29, 2001
Gravitational microlensing by low-mass objects in the globular cluster M22K C Sahu, S Casertano, M Livio, et al.
Journal of Neuroimmunology|September 14, 2020
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetateE Signoriello, P Iardino, S Casertano, et al.
European Journal of Neurology|October 10, 2018
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosisE Signoriello, G Lus, R Polito, et al.
Multiple Sclerosis and Related Disorders|January 28, 2020
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case seriesE Signoriello, S Bonavita, L Sinisi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Neurology|September 3, 2020
Ocrelizumab in a case of refractory chronic inflammatory demyelinating polyneuropathy with anti-rituximab antibodiesS Casertano, E Signoriello, F Rossi, et al.
Multiple Sclerosis and Related Disorders|May 26, 2020
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumabE Signoriello, S Bonavita, A Di Pietro, et al.
Nature|June 29, 2001
Gravitational microlensing by low-mass objects in the globular cluster M22K C Sahu, S Casertano, M Livio, et al.
Journal of Neuroimmunology|September 14, 2020
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetateE Signoriello, P Iardino, S Casertano, et al.
European Journal of Neurology|October 10, 2018
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosisE Signoriello, G Lus, R Polito, et al.
Multiple Sclerosis and Related Disorders|January 28, 2020
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case seriesE Signoriello, S Bonavita, L Sinisi, et al.
Pageof 1